Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

LCAT

High-density lipoproteins (HDL) have much longer life spans in the body (5 to 6 days) than other lipoproteins. Newly formed HDL contains virtually no cholesterol ester. However, over time, cholesterol esters are accumulated through the action of lecithin cholesterol acyltransferase (LCAT), a 59-kD glycoprotein associated with HDLs. Another associated protein, cholesterol ester transfer protein, transfers some of these esters to VLDL and LDL. Alternatively, HDLs function to return cholesterol and cholesterol esters to the liver. This latter process apparently explains the correlation between high HDL levels and reduced risk of cardiovascular disease. (High LDL levels, on the other hand, are correlated with an increased risk of coronary artery and cardiovascular disease.)... [Pg.845]

Lysolecithin (lysophosphatidylcholine) may be formed by an alternative route that involves lecithin cholesterol acyltransferase (LCAT). This enzyme. [Pg.200]

HDL is synthesized and secreted from both liver and intestine (Figure 25—5). However, apo C and apo E are synthesized in the liver and transferred from fiver HDL to intestinal HDL when the latter enters the plasma. A major function of HDL is to act as a repository for the apo C and apo E required in the metabohsm of chylomicrons and VLDL. Nascent HDL consists of discoid phosphohpid bilayers containing apo A and free cholesterol. These hpoproteins are similar to the particles found in the plasma of patients with a deficiency of the plasma enzyme lecithimcholesterol acyltransferase (LCAT) and in the plasma of patients with obstructive jaundice. LCAT—and the LCAT activator apo A-I— bind to the disk, and the surface phosphohpid and free cholesterol are converted into cholesteryl esters and... [Pg.209]

Figure 25-5. Metabolism of high-density lipoprotein (HDL) in reverse cholesteroi transport. (LCAT, lecithinxholesterol acyltransferase C, cholesterol CE, cholesteryl ester PL, phospholipid A-l, apolipoprotein A-l SR-Bl, scavenger receptor B1 ABC-1, ATP binding cassette transporter 1.) Prep-HDL, HDLj, HDL3—see Table 25-1. Surplus surface constituents from the action of lipoprotein lipase on chylomicrons and VLDL are another source of preP-HDL. Hepatic lipase activity is increased by androgens and decreased by estrogens, which may account for higher concentrations of plasma HDLj in women. Figure 25-5. Metabolism of high-density lipoprotein (HDL) in reverse cholesteroi transport. (LCAT, lecithinxholesterol acyltransferase C, cholesterol CE, cholesteryl ester PL, phospholipid A-l, apolipoprotein A-l SR-Bl, scavenger receptor B1 ABC-1, ATP binding cassette transporter 1.) Prep-HDL, HDLj, HDL3—see Table 25-1. Surplus surface constituents from the action of lipoprotein lipase on chylomicrons and VLDL are another source of preP-HDL. Hepatic lipase activity is increased by androgens and decreased by estrogens, which may account for higher concentrations of plasma HDLj in women.
Figure 26-5. Factors affecting cholesterol balance at the cellular level. Reverse cholesterol transport may be initiated by pre 3 HDL binding to the ABC-1 transporter protein via apo A-l. Cholesterol is then moved out of the cell via the transporter, lipidating the HDL, and the larger particles then dissociate from the ABC-1 molecule. (C, cholesterol CE, cholesteryl ester PL, phospholipid ACAT, acyl-CoA cholesterol acyltransferase LCAT, lecithinicholesterol acyltransferase A-l, apolipoprotein A-l LDL, low-density lipoprotein VLDL, very low density lipoprotein.) LDL and HDL are not shown to scale. Figure 26-5. Factors affecting cholesterol balance at the cellular level. Reverse cholesterol transport may be initiated by pre 3 HDL binding to the ABC-1 transporter protein via apo A-l. Cholesterol is then moved out of the cell via the transporter, lipidating the HDL, and the larger particles then dissociate from the ABC-1 molecule. (C, cholesterol CE, cholesteryl ester PL, phospholipid ACAT, acyl-CoA cholesterol acyltransferase LCAT, lecithinicholesterol acyltransferase A-l, apolipoprotein A-l LDL, low-density lipoprotein VLDL, very low density lipoprotein.) LDL and HDL are not shown to scale.
Plasma LCAT Is Responsible for Virtually All Plasma Cholesteryl Ester in Humans... [Pg.224]

LCAT activity is associated with HDL containing apo A-L As cholesterol in HDL becomes esterified, it cre-... [Pg.224]

This protein is found in plasma of humans and many other species, associated with HDL. It facilitates transfer of cholesteryl ester from HDL to VLDL, IDL, and LDL in exchange for triacylglycerol, relieving product inhibition of LCAT activity in HDL. Thus, in humans, much of the cholesteryl ester formed by LCAT finds its way to the hver via VLDL remnants (IDL) or LDL (Figure 26-6). The triacylglycerol-enriched HDL2 delivers its cholesterol to the hver in the HDL cycle (Figure 25-5). [Pg.224]

Figure 26-6. Transport of cholesterol between the tissues in humans. (C, unesterified choiesterol CE, cho-iesteryi ester TG, triacyigiyceroi VLDL, very iow density iipoprotein iDL, intermediate-density iipoprotein LDL, iow-density iipoprotein HDL, high-density iipoprotein ACAT, acyi-CoA choiesteroi acyitransferase LCAT, iecithinxhoiesteroi acyitransferase A-i, apoiipoprotein A-i CETP, choiesteryi ester transfer protein LPL, lipoprotein iipase HL, hepatic iipase LRP, LDL receptor-reiated protein.)... Figure 26-6. Transport of cholesterol between the tissues in humans. (C, unesterified choiesterol CE, cho-iesteryi ester TG, triacyigiyceroi VLDL, very iow density iipoprotein iDL, intermediate-density iipoprotein LDL, iow-density iipoprotein HDL, high-density iipoprotein ACAT, acyi-CoA choiesteroi acyitransferase LCAT, iecithinxhoiesteroi acyitransferase A-i, apoiipoprotein A-i CETP, choiesteryi ester transfer protein LPL, lipoprotein iipase HL, hepatic iipase LRP, LDL receptor-reiated protein.)...
Familial lecithimcholesterol acyltransferase (LCAT) deficiency Absence of LCAT leads to block in reverse cholesterol transport. HDL remains as nascent disks incapable of taking up and esterifying cholesterol. Plasma concentrations of cholesteryl esters and lysolecithin are low. Present is an abnormal LDL fraction, lipoprotein X, found also in patients with cholestasis. VLDL is abnormal ( 3-VLDL). [Pg.228]

FIGURE 9. Endogenous lipoprotein metabolism. In liver cells, cholesterol and triglycerides are packaged into VLDL particles and exported into blood where VLDL is converted to IDL. Intermediate-density lipoprotein can be either cleared by hepatic LDL receptors or further metabolized to LDL. LDL can be cleared by hepatic LDL receptors or can enter the arterial wall, contributing to atherosclerosis. Acetyl CoA, acetyl coenzyme A Apo, apolipoprotein C, cholesterol CE, cholesterol ester FA, fatty acid HL, hepatic lipase HMG CoA, 3-hydroxy-3-methyglutaryl coenzyme A IDL, intermediate-density lipoprotein LCAT, lecithin-cholesterol acyltransferase LDL, low-density lipoprotein LPL, lipoprotein lipase VLDL, very low-density lipoprotein. [Pg.178]

ApoC-I is expressed mainly in liver but also in lung, skin, testis, spleen, neural retina, and RPE. Its multiple functions include the activation of lecithin cholesterol acyltransferase (LCAT) and the inhibition, among others, of lipoprotein and hepatic lipases that hydrolyze triglycerides in particle cores. Notably, both LCAT and lipoprotein lipases are expressed in RPE and choroid (Li et al., 2006). Moreover ApoC-I has been shown to displace ApoE on the VLDL and LDL and thus hinder their binding and uptake via their corresponding receptors (Li et al., 2006). [Pg.319]

HDL particles will remove cholesterol from cells and the component enzyme LCAT esterifies cholesterol whilst it is part of the HDL... [Pg.164]

HDL Picks up cholesterol accumulating in blood vessels Delivers cholesterol to liver and steroidogenic tissues via scavenger receptor (SR-BI) Shuttles apoC-II and apoE in blood apoA-1 Activates lecithin cholesterol acylwansferase (LCAT) to produce cholesterol esters... [Pg.211]

LCAT, lecithin cholesterol acyltransferase CETP, cholesterol ester transfer protein SR-61, scavenger receptor-BI... [Pg.212]

ICAT (or PCAT, phosphatidylcholine-cholesterol acyltransferase) is an enzyme in the blood that is activated by apoA-1 on HDL. LCAT adds a fatty add to cholesterol, producing cholesterol esters, which dissolve in the core of the HDL, allowing HDL to transport cholesterol from the periphery to the liver. This process of reverse cholesterol transport is shown in Figure 1-15-7. [Pg.215]

HDL may be protective by picking up accumulating cholesterol before the advanced lesion forms. Apo-1 activates LCAT, which in turn adds a fetty acid to cholesterol to produce a cholesterol ester that dissolves in the core of the HDL. [Pg.217]

Answer B. The findings are indicative of heterozygous TVpe 11a familial hypercholesterolemia, an autosomal dominant disease. Deficient CETP, LCAT or fatty acid CoA synthetase would not elevate LDL cholesterol. VLDL are not produced from LDL. [Pg.224]

Figure 11.15 The reaction catalysed by lecithin cholesterol acyltransferase (LCAT). LinoLeate is transferred from a phospholipid in the blood to cholesterol to form cholesteryl linoleate, catalysed by LCAT. The cholesterol ester forms the core of HDL, which transfers cholesterol to the liver. Discoidal HDL (i.e. HDL3) is secreted by the liver and collects cholesterol from the peripheral tissues, especially endothellial cells (see Figure 22.10). Cholesterol is then esterified with lin-oleic acid and HDL changes its structure (HDL2) to a more stable form as shown in the lower part of the figure. R is linoleate. Figure 11.15 The reaction catalysed by lecithin cholesterol acyltransferase (LCAT). LinoLeate is transferred from a phospholipid in the blood to cholesterol to form cholesteryl linoleate, catalysed by LCAT. The cholesterol ester forms the core of HDL, which transfers cholesterol to the liver. Discoidal HDL (i.e. HDL3) is secreted by the liver and collects cholesterol from the peripheral tissues, especially endothellial cells (see Figure 22.10). Cholesterol is then esterified with lin-oleic acid and HDL changes its structure (HDL2) to a more stable form as shown in the lower part of the figure. R is linoleate.
DAG diacylglycerol LCAT lecithin-cholesterol acyl transferase... [Pg.560]

The HDLs also originate in the liver. They return the excess cholesterol formed in the tissues to the liver. While it is being transported, cholesterol is acylated by lecithin cholesterol acyltransferase (LCAT). The cholesterol esters formed are no longer amphipathic and can be transported in the core of the lipoproteins. In addition, HDLs promote chylomicron and VLDL turnover by exchanging lipids and apoproteins with them (see above). [Pg.278]

Phosphatidylcholine-sterol acyltransferase— lecithin-cholesterol acyltransferase (LCAT) ... [Pg.423]


See other pages where LCAT is mentioned: [Pg.684]    [Pg.697]    [Pg.699]    [Pg.1160]    [Pg.1495]    [Pg.210]    [Pg.210]    [Pg.223]    [Pg.229]    [Pg.177]    [Pg.178]    [Pg.193]    [Pg.559]    [Pg.354]    [Pg.269]    [Pg.271]    [Pg.387]    [Pg.117]    [Pg.178]    [Pg.318]    [Pg.318]    [Pg.197]    [Pg.215]    [Pg.217]    [Pg.235]    [Pg.279]   
See also in sourсe #XX -- [ Pg.82 ]

See also in sourсe #XX -- [ Pg.340 ]

See also in sourсe #XX -- [ Pg.315 ]

See also in sourсe #XX -- [ Pg.83 , Pg.84 , Pg.91 , Pg.93 ]




SEARCH



High-density lipoproteins as substrate for LCAT

LCAT activity

LCAT acyltransferase

LCAT deficiency

LCAT in plasma

Lecithimcholesterol acyltransferase LCAT)

Lecithin LCAT)

Lecithin cholesterol acyl transferase (LCAT

Lecithin-cholesterol acyltransferase LCAT)

© 2024 chempedia.info